SCHEMBL4894868

SCHEMBL4894868

O=C(O)c1[nH]c2ccc(NS(=O)(=O)c3ccc(-c4ccccc4)cc3)cc2c1-c1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.55
KMT2A Q03164 5/20 0.55
GFER P55789 4/20 0.55
KDM4E B2RXH2 2/20 0.55
ALDH1A1 P00352 2/20 0.55
HPGD P15428 2/20 0.55
HTT P42858 1/20 0.55
HSD17B10 Q99714 1/20 0.55
MAP2 P11137 1/20 0.55
MAPT P10636 1/20 0.54
PDE3A Q14432 1/20 0.54
SERPINE1 P05121 2/20 0.53
CA1 P00915 2/20 0.53
CA2 P00918 2/20 0.53
CA12 O43570 1/20 0.53
CA4 P22748 1/20 0.53
CA6 P23280 1/20 0.53
CA5A P35218 1/20 0.53
CA7 P43166 1/20 0.53
CA9 Q16790 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3945167 0.89 BRD4 (0.61) MEN1KMT2AGFERKDM4EALDH1A1
Dimethylamine SCHEMBL4931369 0.88 BRD4 (0.59) MEN1KMT2AGFERKDM4EALDH1A1
SCHEMBL4889486 0.87 SERPINE1 (0.59) MEN1KMT2AGFERKDM4EALDH1A1
SCHEMBL3951941 0.84 BRD4 (0.56) MEN1KMT2AGFERKDM4EALDH1A1
SCHEMBL3958387 0.84 SERPINE1 (0.49) MEN1KMT2AGFERKDM4EALDH1A1
SCHEMBL3947323 0.83 BRD4 (0.54) MEN1KMT2AGFERKDM4EALDH1A1
SCHEMBL4930867 0.83 UQCRB (0.56) MEN1KMT2AGFERKDM4EALDH1A1
SCHEMBL4762476 0.83 BRD4 (0.53) MEN1KMT2AGFERKDM4EALDH1A1
SCHEMBL4933597 0.82 GPR35 (0.53) MEN1KMT2AGFERALDH1A1MAPT
SCHEMBL3946651 0.82 BRD4 (0.53) MEN1KMT2AGFERALDH1A1MAP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080319046-A1 SUBSTITUTED SULFONAMIDE-INDOLES WYETH (US) 2008-12-25 US claimed
US-7442805-B2 Substituted sulfonamide-indoles WYETH (US) 2008-10-28 US claimed
JP-2007506769-A 2007-03-22 JP claimed
EP-1667969-A1 SUBSTITUTED SULFONAMIDE-INDOLE-2-CARBOXYLIC ACID DERIVATIVES AS PAI-1 INHIBITORS Wyeth (US) 2006-06-14 EP claimed
US-20050096377-A1 Substituted sulfonamide-indoles WYETH (US) 2005-05-05 US claimed
WO-2005030715-A1 SUBSTITUTED SULFONAMIDE-INDOLE-2-CARBOXYLIC ACID DERIVATIVES AS PAI-1 INHIBITORS WYETH (US) 2005-04-07 WO claimed
US-20080319046-A1 SUBSTITUTED SULFONAMIDE-INDOLES WYETH (US) 2008-12-25 US disclosed
US-7442805-B2 Substituted sulfonamide-indoles WYETH (US) 2008-10-28 US disclosed
EP-1667969-A1 SUBSTITUTED SULFONAMIDE-INDOLE-2-CARBOXYLIC ACID DERIVATIVES AS PAI-1 INHIBITORS Wyeth (US) 2006-06-14 EP disclosed
US-20050096377-A1 Substituted sulfonamide-indoles WYETH (US) 2005-05-05 US disclosed
WO-2005030715-A1 SUBSTITUTED SULFONAMIDE-INDOLE-2-CARBOXYLIC ACID DERIVATIVES AS PAI-1 INHIBITORS WYETH (US) 2005-04-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080319046-A1 SUBSTITUTED SULFONAMIDE-INDOLES STS, TPST2, IDO2 MEN1 3530/4885KMT2A 172/4885GFER 263/4885
US-20050096377-A1 Substituted sulfonamide-indoles STS, TPST2, IDO2 MEN1 3530/4885KMT2A 172/4885GFER 263/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.